NeoGenomics, Inc. (NEO) Financials

NEO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.7 billion 739.7 million
2023-09-30 1.7 billion 730.8 million
2023-06-30 1.7 billion 738.9 million
2023-03-31 1.7 billion 734.7 million

NEO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 10.7 million 7.0 million
2023-09-30 -9.8 million 7.2 million
2023-06-30 -9.0 million 5.7 million
2023-03-31 -22.6 million 4.8 million

NEO Net Income

No data available :(

NEO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 415.2 million - 73.5 million
2023-09-30 402.3 million - 68.2 million
2023-06-30 409.3 million 536.8 million 72.8 million
2023-03-31 417.9 million 536.0 million 74.3 million

NEO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 125.9 million
2023-09-30 125.7 million
2023-06-30 125.4 million
2023-03-31 125.0 million

NEO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 7.1 million 7.1 million 59.8 million 18.1 million
2023-09-30 4.3 million 5.3 million 61.5 million 17.6 million
2023-06-30 7.5 million 7.5 million 60.3 million 18.9 million
2023-03-31 9.9 million 7.4 million 61.5 million 16.3 million

NEO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 155.6 million 88.0 million
2023-09-30 152.0 million 89.6 million
2023-06-30 146.9 million 87.0 million
2023-03-31 137.2 million 82.4 million

NEO

Price: $14.72

52 week price:
11.03
21.22

Payout Ratio Range:
-472.10%
639.53%

Earnings Per Share: -0.70 USD

P/E Ratio: -18.65

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 437800

Ebitda: 2.2 million

Market Capitalization: 1.9 billion

Links: